Cyclosporin A-induced Gingival Overgrowth is Closely Associated with Regulation Collagen Synthesis by the Beta Subunit of Prolyl 4-hydroxylase and Collagen Degradation by Testican 1- mediated Matrix Metalloproteinase- 2 Expression
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Gingival overgrowth can cause dental occlusion and seriously interfere with mastication, speech, and dental hygiene. It is observed in 25 to 81 % of renal transplant patients treated with cyclosporine A (CsA). CsA-induced gingival overgrowth (CIGO) is caused by quantitative alteration of the extracellular matrix components, particularly collagen. However, the molecular mechanisms involved in the pathogenesis of CIGO remain poorly understood, despite intense clinical and laboratory investigations. The aim of the present work is to identify differentially expressed genes closely associated with CIGO. Human gingival fibroblasts were isolated by primary explant culture of gingival tissues from five healthy subjects (HGFs) and two patients with the CIGO (CIGO-HGFs). The proliferative activity of CsA-treated HGFs and CIGOHGFs was examined using the MTT assay. The identification of differentially expressed genes in CsAtreated CIGO-HGF was performed by differential display reverse transcriptase-polymerase chain reaction (RT-PCR) followed by DNA sequencing. CsA significantly increased the proliferation of two HGFs and two CIGO-HGFs, whereas three HGFs were not affected. Seven genes, including the beta subunit of prolyl 4-hydroxylase (P4HB) and testican 1, were upregulated by CsA in a highly proliferative CIGO-HGF. The increased P4HB and testican-1 mRNA levels were confirmed in CsA-treated CIGO-HGFs by semiquantitative RT-PCR. Furthermore, CsA increased type I collagen mRNA levels and suppressed MMP-2 mRNA levels, which are regulated by P4HB and testican-1, respectively. These results suggest that CsA may induce gingival overgrowth through the upregulation of P4HB and testican-1, resulting in the accumulation of extracellular matrix components.
Abstract
Gingival overgrowth can cause dental occlusion and seriously interfere with mastication, speech, and dental hygiene. It is observed in 25 to 81 % of renal transplant patients treated with cyclosporine A (CsA). CsA-induced gingival overgrowth (CIGO) is caused by quantitative alteration of the extracellular matrix components, particularly collagen. However, the molecular mechanisms involved in the pathogenesis of CIGO remain poorly understood, despite intense clinical and laboratory investigations. The aim of the present work is to identify differentially expressed genes closely associated with CIGO. Human gingival fibroblasts were isolated by primary explant culture of gingival tissues from five healthy subjects (HGFs) and two patients with the CIGO (CIGO-HGFs). The proliferative activity of CsA-treated HGFs and CIGOHGFs was examined using the MTT assay. The identification of differentially expressed genes in CsAtreated CIGO-HGF was performed by differential display reverse transcriptase-polymerase chain reaction (RT-PCR) followed by DNA sequencing. CsA significantly increased the proliferation of two HGFs and two CIGO-HGFs, whereas three HGFs were not affected. Seven genes, including the beta subunit of prolyl 4-hydroxylase (P4HB) and testican 1, were upregulated by CsA in a highly proliferative CIGO-HGF. The increased P4HB and testican-1 mRNA levels were confirmed in CsA-treated CIGO-HGFs by semiquantitative RT-PCR. Furthermore, CsA increased type I collagen mRNA levels and suppressed MMP-2 mRNA levels, which are regulated by P4HB and testican-1, respectively. These results suggest that CsA may induce gingival overgrowth through the upregulation of P4HB and testican-1, resulting in the accumulation of extracellular matrix components.
참고문헌 (28)
- Alliel PM, "Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour", European Journal of Biochemistry, 214, pp.347~350 (1993)
- Aoyagi M, "Prolyl 4-hydroxylase inhibitor is more effective for the inhibition of proliferation than for inhibition of collagen synthesis of rat hepatic satellite cells", HEPATOLOGY RESEARCH, 23, pp.1~6 (2002)
- Atilla G, "N. Cervicular fluid interleukin-1β, tumor necrosis factor-α, and interleukin-8 levels in renal transplant patients receiving cyclosporin A", Journal of Periodontology, 69, pp.784~890 (1998)
- Barber MT, "The effect of cyclosporin and lipopolysaccharide on fibroblasts: implications for cyclosporin-induced gingival overgrowth", Journal of Periodontology, 63, pp.397~404 (1992)
- Bartold PM, "Regulation of human gingival fibroblast growth and synthetic activity by cyclosporin-A in vitro", Journal of Periodontal Research, 24, pp.314~321 (1989)
- Bocock JP, "Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L", European Journal of Biochemistry, 270, pp.4008~4015 (2003)
- Bolzani G, "Martelli Junior H, Martelli Junior H, Graner E. Cyclosporin A inhibits production and activity of matrix metalloproteinases by gingival fibroblasts", Journal of Periodontal Research, 35, pp.51~58 (2000)
- Bonnaure-Mallet M, "Changes in extracellular matrix macromolecules in human gingival after treatment with drugs inducing gingival overgrowth", Archives of Oral Biology, 40, pp.393~400 (1995)
- Cai H, "Chaperone-like activity of protein disulfide isomerase in the refolding of a protein with no disulfide bonds", Archives of Oral Biology, 269, pp.24550~24552 (1994)
- Cotrim P, "Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation", Journal of Periodontology, 73, pp.1313~1322 (2002)
- Gagliano N, "Effect of cyclosporin A on human gingival fibroblast collagen turnover in relation to the development of gingival overgrowth: an in vitro study", BIOMEDICINE AND PHARMACOTHERAPY, 58, pp.231~238 (2004)
- Hyland PL, "The effects of cyclosporin on the collagenolytic activity of gingival fibroblasts", Journal of Periodontology, 74, pp.437~445 (2003)
- John DC, "Cell-free synthesis and assembly of prolyl 4-hydroxylase: the role of the betasubunit (PDI) in preventing misfolding and aggregation of the alpha-subunit", EMBO Journal, 12, pp.1587~1595 (1993)
- Kim JY, "Mechanism of azithromycin treatment on gingival overgrowth", Journal of Dental Research, 87, pp.1075~1079 (2008)
- Ko MK, "PDI-mediated ER retention and proteasomal degradation of procollagen I in corneal endothelial cells", EXPERIMENTAL CELL RESEARCH, 295, pp.25~35 (2004)
- Koivu J, "Protein disulfide-isomerase retains procollagen prolyl 4-hydroxylase structure in its native conformation", Biochemistry, 25, pp.5982~5986 (1986)
- Koivu J, "Interchain disulfide bond formation in types I and II procollagen. Evidence for a protein disulfide isomerase catalyzing bond formation.", Journal of Biological Chemistry, 262, pp.6159~6164 (1987)
- Koivu J, "A single polypeptide acts both as the beta subunit of prolyl 4-hydroxylase and as a protein disulfideisomerase", Journal of Biological Chemistry, 262, pp.6447~6449 (1987)
- Nakada M, "Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins", Cancer Research, 63, pp.3364~3369 (2003)
- Nakada M, "Suppression of membrane type I matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes", Cancer Research, 61, pp.8896~8902 (2001)
- Nares S, "Cyclosporin A upregulates platelet-derived growth factor B chain in human hyperplastic gingiva", Journal of Periodontology, 67, pp.271~278 (1996)
- 박지일, "Involvement of Antiapoptotic Signals in Rat PC12 Cells Proliferation by Cyclosporin A Treatment", International Journal of Oral Biology, 32(2), pp.51~57 (2007), 대한구강생물학회
- Schincaglia GP, "Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro", JOURNAL OF ORAL PATHOLOGY & MEDICINE, 21, pp.181~185 (1992)
- Swarga JD, "Upregulation of keratinocyte growth factor in cyclosporin A-induced gingival overgrowth", Journal of Periodontology, 72, pp.745~752 (2001)
- Tipton DA, "Fibroblast heterogeneity in collagenolytic response to cyclosporine", Journal of Cellular Biochemistry, 46, pp.152~165 (1991)
- Tyldesley WR, "Gingival hyperplasia induced by cyclosporin A", BRITISH DENTAL JOURNAL, 157, pp.305~309 (1984)
- Wysocki GP, "Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapy", Oral Surgery Oral Medicine and Oral Pathology, 55, pp.274~278 (1983)
- Yamada H, "Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts", Journal of Periodontology, 71, pp.955~960 (2000)